Small Pharma Inc.
Small Pharma Inc. (DMTTF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
dmttf · pe ratio · data through Feb 28, 2023
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Small Pharma Inc. (DMTTF) measures how much investors pay for each dollar of the company's trailing earnings. DMTTF's current PE ratio of N/A is calculated by dividing its stock price of $0.11 by its TTM earnings per share of -$0.07.
Source: FMP · /ratios-ttm · /analyst-estimates · 2023-02-28
PE Ratio History
2020 – 2023 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Small Pharma Inc.You DMTTF | $38M | N/A | — | -$0.07 |
 Alpha Cognition Inc. ACOGF | $36M | N/A | — | -$0.15 |
 China Shineway Pharmaceutical Group Limited CSWYY | $36M | 0.28x | — | $489.31 |
 Enzo Biochem, Inc. ENZB | $37M | N/A | — | -$0.51 |
 IntelGenx Technologies Corp. IGXT | $30M | N/A | — | -$0.06 |
 ImmuPharma plc IMMPF | $28M | N/A | — | — |
 LakeShore Biopharma Co., Ltd LSBCF | $3M | N/A | — | -$0.94 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2023-02-28Latest FY2023 | — | $-0.07 | — | |
2022-02-28 FY2022 | — | $-0.07 | — | |
2021-02-28 FY2021 | — | $-0.02 | — | |
2020-02-29 FY2020 | — | $0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Small Pharma Inc. (DMTTF) measures how much investors pay for each dollar of the company's trailing earnings. DMTTF's current PE ratio of N/A is calculated by dividing its stock price of $0.11 by its TTM earnings per share of -$0.07.
Frequently asked questions
DMTTF pe ratio · 6 questionsDMTTF's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.11 and TTM EPS of -$0.07. Data sourced from Financial Modeling Prep via DMTTF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Small Pharma Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08